More bonyf NV news
bonyf NVEURONEXT: MLBON

Bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream

May 15, 2025 at 11:19 AM EDT · Issued by bonyf NV

On 6ix: 6ix.com/news/bonyf-advances-to-phase-3-in-the-development-of-alginate-organic-denture-fixative-cream

April 8, 2025April 8, 2025
0

bonyf NV on 6ix

Earlier from bonyf

  • Bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS CologneMar 13, 2025
  • Bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step StrategyFeb 18, 2025
  • Bonyf R&D presents its two latest innovations at IDS 2025 in CologneJan 30, 2025
  • Bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US marketDec 10, 2024
  • Bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care SolutionsDec 9, 2024

Later from bonyf

  • Bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth StrategyMay 15, 2025
  • Bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in IndiaJun 3, 2025
  • Annual Results 2024Jun 30, 2025
  • Bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market VolatilityJul 14, 2025
  • Periocream: The Future Commercial Winner for bonyfAug 11, 2025
All bonyf news releases↗

Follow bonyf into a list and get an email when it puts out news.

Follow bonyf
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer